Palantir Slumps: Bubble or Breakout?
Billion-dollar AI darling stumbles—does valuation alarm outpace growth potential?
Palantir is trending downward amid a short seller’s report that casts serious doubts on its lofty valuation, igniting debate over whether its explosive rise has detached from reality. Today, Palantir Technologies Inc. (PLTR)—a leading software and AI company trading on the NASDAQ—dipped about 5% to $148, extending a sixth straight day of declines and sliding nearly 20% below its August 12 all-time high of $190. Even so, it remains one of the year’s biggest gainers in the S&P 500, still up roughly 110% in 2025.
The plunge was triggered by a blistering critique from Andrew Left of Citron Research, who accused Palantir of being “detached from fundamentals” and suggested its fair value may be closer to $40, should its multiples align with those of OpenAI. Yet even that puts it among the priciest SaaS stocks ever. As of now, PLTR trades at a forward P/E ratio north of 200x, compared to the S&P 500 average of about 22x.
And these are not idle claims. A recent report warns that Palantir may be one of the most overvalued large-cap names ever, drawing worrying parallels to past tech and biotech bubbles. Meanwhile, broader fears about an AI-driven valuation peak contributed to simultaneous sell-offs in other leaders like NVIDIA (NVDA – Technology – NASDAQ).
Still, the financials were anything but weak. Palantir’s Q2 results exceeded expectations with revenue surpassing $1 billion and year-over-year growth over 48%. U.S. government revenue surged 53%, and commercial growth hit 93%. The company raised its full-year outlook to $4.14–$4.15 billion, signaling 45% annual growth, and cemented its place at the top of the S&P 500 pecking order.
That rally has minted fortunes: CEO Alex Karp has reportedly seen his net worth double to around $14.3 billion, while co-founders like Peter Thiel are now tech billionaires too. And yet, Wall Street sentiment remains split—only a handful of analysts still rate the stock a “buy,” with many calling it “hold” or “sell,” and price targets scattered between $45 and $210.
So here’s the story: Palantir represents a high-stakes tug-of-war between narrative and numbers, mesmerized investors and skeptical value-seekers. Its AI platform continues to expand in healthcare, defense, and logistics, even as the valuation qualifies as extreme on almost every metric.
If you’re watching PLTR, the key questions are clear—when the dust settles, will this sell-off be seen as a premium buying opportunity, or the turning point of an overheated run? As ever, Palantir’s trajectory is a mirror for markets wrestling with their biggest bubble fears—and boldest growth dreams.